Familial cancer: how to successfully recruit families for germline mutations studies? Multiple myeloma as an example

Introduction - Identification of germline mutations related to an increased cancer risk enables diagnostic, preventive, and therapeutic measures for individuals carrying the disease variant. However, recruitment of families for studies on these mutations can be challenging. Herein we present some of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Blocka, Joanna (VerfasserIn) , Durie, Brian G. M. (VerfasserIn) , Huhn, Stefanie (VerfasserIn) , Müller-Tidow, Carsten (VerfasserIn) , Försti, Asta (VerfasserIn) , Hemminki, Kari (VerfasserIn) , Goldschmidt, Hartmut (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 4 July 2019
In: Clinical lymphoma, myeloma & leukemia
Year: 2019, Jahrgang: 19, Heft: 10, Pages: 635-644.e2
ISSN:2152-2669
DOI:10.1016/j.clml.2019.06.012
Online-Zugang:Verlag, Volltext: https://doi.org/10.1016/j.clml.2019.06.012
Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S2152265019302496
Volltext
Verfasserangaben:Joanna Blocka, Brian G.M. Durie, Stefanie Huhn, Carsten Mueller-Tidow, Asta Försti, Kari Hemminki, Hartmut Goldschmidt

MARC

LEADER 00000caa a2200000 c 4500
001 1684105544
003 DE-627
005 20230426071237.0
007 cr uuu---uuuuu
008 191203s2019 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.clml.2019.06.012  |2 doi 
035 |a (DE-627)1684105544 
035 |a (DE-599)KXP1684105544 
035 |a (OCoLC)1341280379 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Blocka, Joanna  |d 1987-  |e VerfasserIn  |0 (DE-588)1163754897  |0 (DE-627)1028116861  |0 (DE-576)508197856  |4 aut 
245 1 0 |a Familial cancer  |b how to successfully recruit families for germline mutations studies? Multiple myeloma as an example  |c Joanna Blocka, Brian G.M. Durie, Stefanie Huhn, Carsten Mueller-Tidow, Asta Försti, Kari Hemminki, Hartmut Goldschmidt 
264 1 |c 4 July 2019 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 02.12.2019 
520 |a Introduction - Identification of germline mutations related to an increased cancer risk enables diagnostic, preventive, and therapeutic measures for individuals carrying the disease variant. However, recruitment of families for studies on these mutations can be challenging. Herein we present some of the obstacles that can arise during such studies. We suggest solutions for overcoming or avoiding these difficulties, enabling an efficient and ethically correct family recruitment. - Patients and Methods - We describe a study on germline mutations associated with familial risk of multiple myeloma using next-generation sequencing of the whole genome. To date, the study has recruited 54 participants/16 families from different centers in Germany. It was performed at the University Hospital of Heidelberg and German Cancer Research Center. - Results - We were confronted with ethical/psychological concerns of patients and family members, a large number of ineligible families, a profound time investment by the participants and the study team, incidental findings, and participants’ death. We present solutions to these difficulties such as: knowledge of and adherence to the laws protecting participants’ rights, an exact clarification of the inclusion and exclusion criteria, a clear division of tasks within members of the study team, a collaboration with general practitioners/oncologists and patients’ support groups, a detailed and understandable informed consent including information about incidental findings, and a choice of a representative in case of participant’s death. - Conclusion - A successful recruitment for studies on familial cancer is challenging, yet possible. It can be facilitated by applying the previously mentioned strategies. 
650 4 |a Familial cancer 
650 4 |a Family studies 
650 4 |a Genome sequencing 
650 4 |a Genomic studies 
650 4 |a Human genetics 
700 1 |a Durie, Brian G. M.  |e VerfasserIn  |4 aut 
700 1 |a Huhn, Stefanie  |d 1982-  |e VerfasserIn  |0 (DE-588)1014984424  |0 (DE-627)705313190  |0 (DE-576)349876436  |4 aut 
700 1 |a Müller-Tidow, Carsten  |d 1968-  |e VerfasserIn  |0 (DE-588)1015101798  |0 (DE-627)705330230  |0 (DE-576)351197893  |4 aut 
700 1 |a Försti, Asta  |e VerfasserIn  |0 (DE-588)1155331672  |0 (DE-627)1017045755  |0 (DE-576)501623833  |4 aut 
700 1 |a Hemminki, Kari  |e VerfasserIn  |4 aut 
700 1 |a Goldschmidt, Hartmut  |d 1956-  |e VerfasserIn  |0 (DE-588)102258023X  |0 (DE-627)717003809  |0 (DE-576)365637386  |4 aut 
773 0 8 |i Enthalten in  |t Clinical lymphoma, myeloma & leukemia  |d Amsterdam [u.a.] : Elsevier, 2010  |g 19(2019), 10, Seite 635-644.e2  |h Online-Ressource  |w (DE-627)620142014  |w (DE-600)2540998-0  |w (DE-576)358408776  |x 2152-2669  |7 nnas  |a Familial cancer how to successfully recruit families for germline mutations studies? Multiple myeloma as an example 
773 1 8 |g volume:19  |g year:2019  |g number:10  |g pages:635-644.e2  |g extent:10  |a Familial cancer how to successfully recruit families for germline mutations studies? Multiple myeloma as an example 
856 4 0 |u https://doi.org/10.1016/j.clml.2019.06.012  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S2152265019302496  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20191203 
993 |a Article 
994 |a 2019 
998 |g 102258023X  |a Goldschmidt, Hartmut  |m 102258023X:Goldschmidt, Hartmut  |d 910000  |d 910100  |e 910000PG102258023X  |e 910100PG102258023X  |k 0/910000/  |k 1/910000/910100/  |p 7  |y j 
998 |g 1155331672  |a Försti, Asta  |m 1155331672:Försti, Asta  |d 50000  |e 50000PF1155331672  |k 0/50000/  |p 5 
998 |g 1015101798  |a Müller-Tidow, Carsten  |m 1015101798:Müller-Tidow, Carsten  |d 910000  |d 910100  |e 910000PM1015101798  |e 910100PM1015101798  |k 0/910000/  |k 1/910000/910100/  |p 4 
998 |g 1014984424  |a Huhn, Stefanie  |m 1014984424:Huhn, Stefanie  |d 910000  |d 910100  |e 910000PH1014984424  |e 910100PH1014984424  |k 0/910000/  |k 1/910000/910100/  |p 3 
998 |g 1163754897  |a Blocka, Joanna  |m 1163754897:Blocka, Joanna  |d 910000  |d 910100  |e 910000PB1163754897  |e 910100PB1163754897  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1684105544  |e 3555976931 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"subtitle":"how to successfully recruit families for germline mutations studies? Multiple myeloma as an example","title_sort":"Familial cancer","title":"Familial cancer"}],"id":{"doi":["10.1016/j.clml.2019.06.012"],"eki":["1684105544"]},"recId":"1684105544","note":["Gesehen am 02.12.2019"],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"4 July 2019"}],"person":[{"family":"Blocka","roleDisplay":"VerfasserIn","given":"Joanna","display":"Blocka, Joanna","role":"aut"},{"given":"Brian G. M.","display":"Durie, Brian G. M.","role":"aut","family":"Durie","roleDisplay":"VerfasserIn"},{"role":"aut","display":"Huhn, Stefanie","given":"Stefanie","family":"Huhn","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","family":"Müller-Tidow","given":"Carsten","role":"aut","display":"Müller-Tidow, Carsten"},{"given":"Asta","role":"aut","display":"Försti, Asta","family":"Försti","roleDisplay":"VerfasserIn"},{"family":"Hemminki","roleDisplay":"VerfasserIn","role":"aut","display":"Hemminki, Kari","given":"Kari"},{"display":"Goldschmidt, Hartmut","role":"aut","given":"Hartmut","family":"Goldschmidt","roleDisplay":"VerfasserIn"}],"name":{"displayForm":["Joanna Blocka, Brian G.M. Durie, Stefanie Huhn, Carsten Mueller-Tidow, Asta Försti, Kari Hemminki, Hartmut Goldschmidt"]},"physDesc":[{"extent":"10 S."}],"relHost":[{"recId":"620142014","titleAlt":[{"title":"Clinical lymphoma, myeloma and leukemia"}],"pubHistory":["10.2010 -"],"title":[{"title":"Clinical lymphoma, myeloma & leukemia","title_sort":"Clinical lymphoma, myeloma & leukemia"}],"id":{"eki":["620142014"],"zdb":["2540998-0"],"issn":["2152-2669"]},"disp":"Familial cancer how to successfully recruit families for germline mutations studies? Multiple myeloma as an exampleClinical lymphoma, myeloma & leukemia","note":["Gesehen am 04.02.20"],"origin":[{"publisher":"Elsevier ; CIG Media Group","dateIssuedDisp":"2010-","publisherPlace":"Amsterdam [u.a.] ; Dallas, Tex.","dateIssuedKey":"2010"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"part":{"extent":"10","year":"2019","pages":"635-644.e2","text":"19(2019), 10, Seite 635-644.e2","volume":"19","issue":"10"}}]} 
SRT |a BLOCKAJOANFAMILIALCA4201